Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Will Testicular Germ Cell Tumors Remain Untargetable?

Aoun F, Kourie HR, Albisinni S, Roumeguère T.

Target Oncol. 2016 May 17. [Epub ahead of print]

PMID:
27184492
2.

Validation of a sensitive LC/MSMS method for chloronucleoside analysis in biological matrixes and its applications.

Noyon C, Delporte C, Dufour D, Cortese M, Rousseau A, Poelvoorde P, Nève J, Vanhamme L, Zouaoui Boudjeltia K, Roumeguère T, Van Antwerpen P.

Talanta. 2016 Jul 1;154:322-8. doi: 10.1016/j.talanta.2016.03.087. Epub 2016 Mar 28.

PMID:
27154681
3.

[Can preoperative prostate MRI before radical prostatectomy predict extracapsular extension and the side of the index lesion?].

Albisinni S, De Groote A, Deneft F, Thoma P, Catteau X, Roumeguère T, Wildschutz T.

Prog Urol. 2016 Apr;26(5):281-6. doi: 10.1016/j.purol.2016.02.006. Epub 2016 Mar 17. French.

PMID:
26996453
4.

Non-metastatic castrate-resistant prostate cancer: a call for improved guidance on clinical management.

Rozet F, Roumeguère T, Spahn M, Beyersdorff D, Hammerer P.

World J Urol. 2016 Mar 17. [Epub ahead of print] Review.

PMID:
26988552
5.

In Search for a Common Pathway for Health Issues in Men--the Sign of a Holmesian Deduction.

Aoun F, Albisinni S, Chemaly AK, Zanaty M, Roumeguère T.

Asian Pac J Cancer Prev. 2016;17(1):1-13. Review.

6.

[Lower urinary tract dysfunction following nerve sparing radical hysterectomy: A systematic review].

Aoun F, Albisinni S, Peltier A, Maoula A, van Velthoven R, Roumeguère T.

Prog Urol. 2015 Nov 19. pii: S1166-7087(15)00690-9. doi: 10.1016/j.purol.2015.10.007. [Epub ahead of print] French.

PMID:
26776826
7.

[Evaluation of adverse events caused by intravesical BCG instillations: Has the strain used a potential implication?].

Holz S, Sotorres Cabanillas JL, Legrand F, Gilsoul J, Pirson M, Roumeguère T.

Prog Urol. 2016 Feb;26(2):73-8. doi: 10.1016/j.purol.2015.11.001. Epub 2015 Dec 17. French.

PMID:
26711556
8.

Checkpoint inhibitors in bladder and renal cancers: results and perspectives.

Aoun F, Kourie HR, Sideris S, Roumeguère T, van Velthoven R, Gil T.

Immunotherapy. 2015;7(12):1259-71. doi: 10.2217/imt.15.91. Epub 2015 Nov 23. Review.

PMID:
26595284
9.

[Aristolochic acid nephropathy ("Chinese herb nephropathy")].

Nortier J, Pozdzik A, Roumeguere T, Vanherweghem JL.

Nephrol Ther. 2015 Dec;11(7):574-88. doi: 10.1016/j.nephro.2015.10.001. Epub 2015 Oct 26. French.

PMID:
26515658
10.

Prévalence et retentissement de l'urgence mictionnelle et des autres symptômes du bas appareil urinaire chez l'homme de 40ans ou plus - une étude épidémiologique belge.

Roumeguère T, De Ridder D, Flamee G, Neuville O, Smets J.

Prog Urol. 2014 Nov;24(13):790. doi: 10.1016/j.purol.2014.08.018. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461544
11.

Does Multimedia Education with 3D Animation Impact Quality and Duration of Urologists' Interactions with their Prostate Cancer Patients?

Peltier A, Aoun F, Ameye F, Andrianne R, De Meerleer G, Denis L, Joniau S, Lambrecht A, Billiet I, Vanderdonck F, Roumeguère T, Van Velthoven R.

Adv Ther. 2015 Sep;32(9):863-73. doi: 10.1007/s12325-015-0248-7. Epub 2015 Sep 25.

PMID:
26407808
12.

Renal and prostate stones composition in alkaptonuria: a case report.

Wolff F, Biaou I, Koopmansch C, Vanden Bossche M, Pozdzik A, Roumeguère T, Cotton F.

Clin Nephrol. 2015 Dec;84(6):339-42. doi: 10.5414/CN108608. Review.

PMID:
26396096
13.

[Recurrent episodes of brushite nephrolithiasis revealing primary hyperparathyroidism].

Simon I, Roumeguère T, Devuyst F, Cotton F, Tang BN, Cappello M, Corbetta S, Idrissi M, Pozdzik A, Nortier J.

Rev Med Brux. 2015 May-Jun;36(3):172-6. French.

PMID:
26372980
14.

[Lower urinary tract dysfunction following radical hysterectomy].

Aoun F, Roumeguère T.

Prog Urol. 2015 Dec;25(17):1184-90. doi: 10.1016/j.purol.2015.08.311. Epub 2015 Sep 8. French.

PMID:
26362076
15.

High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis.

Aoun F, Limani K, Peltier A, Marcelis Q, Zanaty M, Chamoun A, Vanden Bossche M, Roumeguère T, van Velthoven R.

Adv Urol. 2015;2015:350324. doi: 10.1155/2015/350324. Epub 2015 Aug 19.

16.

Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update.

Aoun F, Marcelis Q, Roumeguère T.

Res Rep Urol. 2015 Aug 19;7:125-36. doi: 10.2147/RRU.S55340. eCollection 2015. Review.

17.

Next revolution in molecular theranostics: personalized medicine for urologic cancers.

Aoun F, Kourie HR, Artigas C, Roumeguère T.

Future Oncol. 2015;11(15):2205-19. doi: 10.2217/fon.15.104. Review.

PMID:
26235183
18.

Diagnostic value of the UCA1 test for bladder cancer detection: a clinical study.

Milowich D, Le Mercier M, De Neve N, Sandras F, Roumeguere T, Decaestecker C, Salmon I, Rorive S.

Springerplus. 2015 Jul 16;4:349. doi: 10.1186/s40064-015-1092-6. eCollection 2015.

19.

[Botulinum toxin injection for refractory non-neurogenic overactive bladder. Systematic review].

Henriet B, Roumeguère T.

Rev Med Brux. 2015 Jan-Feb;36(1):29-37. Review. French.

PMID:
25856969
20.

[Contribution of clinical biology in the etiological exploration and follow-up of urolithiasis].

Cotton F, Wolff F, Simon I, Idrissi M, Tielemans C, Vanden Bossche M, Roumeguère T, Pozdzik A.

Rev Med Brux. 2014 Sep;35(4):243-9. French.

PMID:
25675626
Items per page

Supplemental Content

Loading ...
Write to the Help Desk